As a purchasing manager or technical director in pharma R&D, you face unreliable assays causing 20-30% data variability, delaying your Type 2 diabetes trials. Our GMP-certified β-Cell Function Assay kit from Global Technology Co., Ltd ensures precise glucose-stimulated insulin secretion (GSIS) measurements, accelerating your ROI with lab-verified results in under 48 hours.
The β-Cell Function Assay is a cornerstone tool in modern biomedical research, particularly for investigating pancreatic β-cell physiology and pathophysiology. β-cells, comprising 50-70% of the islets of Langerhans in the pancreas, are the primary insulin-producing cells responsible for glucose homeostasis. Dysfunctional β-cells underlie Type 1 and Type 2 diabetes, affecting over 537 million adults globally in 2021, per the International Diabetes Federation, with projections reaching 783 million by 2045.
At its core, a β-Cell Function Assay evaluates key functional parameters: insulin secretion dynamics, glucose responsiveness, cell viability, and stress responses. Traditional methods like the Homeostatic Model Assessment of β-cell function (HOMA-B) rely on fasting glucose and insulin levels but lack cellular resolution. Advanced in vitro assays, such as our kit, bridge this gap by using primary rodent/human islets, INS-1E cell lines, or iPSC-derived β-cells to measure real-time responses.
The gold standard is the Glucose-Stimulated Insulin Secretion (GSIS) assay. Here, β-cells are sequentially exposed to low (2.8 mM) and high (16.7 mM) glucose concentrations. Healthy β-cells exhibit a biphasic insulin release: a rapid first phase (triggered by Ca²⁺ influx via voltage-gated channels) followed by a sustained second phase (amplified by KATP channel closure and metabolic amplification). Our β-Cell Function Assay kit optimizes this with proprietary peptides and buffers, achieving 95% reproducibility across batches, far surpassing generic kits with 25% variability reported in a 2023 Nature Protocols study.
Technically, the assay involves:
In diabetes research, impaired first-phase insulin secretion signals early β-cell exhaustion, a hallmark of prediabetes. Our assay detects this with 2-fold sensitivity over competitors, enabling high-throughput screening (HTS) of 1,000+ compounds/day. For regenerative medicine, it assesses stem cell-derived β-like cells' maturity, correlating GSIS fold-induction (>5x) with transplant success, as per a 2024 Cell Stem Cell paper.
Regulatory compliance is paramount for USA markets. Our kits include DMF/FDA-grade reagents, RoHS-compliant packaging, and COAs traceable to NIST standards. Unlike low-quality imports plagued by endotoxin contamination (>10 EU/mg), ours maintain <0.1 EU/mg, preventing false positives in GLP-1 agonist studies.
Historically, β-cell assays evolved from radiolabeled glucose uptake (1960s) to fluorescence-based systems today. Challenges persist: batch-to-batch variability from serum lots, poor human islet availability (only 1-2 million/year worldwide), and species differences (rodent vs. human GSIS kinetics differ by 30%). Our OEM/ODM service customizes with human-relevant peptides, reducing translation failure rates by 40%, per internal data from 50+ collaborations.
Quantitatively, a robust β-Cell Function Assay yields:
| Parameter | Healthy β-Cells | T2D Model |
|---|---|---|
| First-Phase Insulin (µU/islet) | 50-100 | <20 |
| GSIS Fold-Induction | 5-10x | <2x |
| EC50 Glucose (mM) | 5-8 | >12 |
cell expression system kinase activity assay cellulase enzyme
This level of detail empowers your team to de-risk preclinical candidates. In toxicology, it flags β-cell apoptosis from chemotherapy (e.g., doxorubicin IC50 <1µM). For SaaS platforms integrating AI-driven analysis, our data exports seamlessly to MATLAB/Python scripts.
Global Technology Co., Ltd's investment in university labs ensures scalability from grams (research) to tons (GMP production). Pricing undercuts USA suppliers by 37% while exceeding quality—proven in 500+ shipments to USA labs annually. Ready to optimize your pipeline? Request a brochure now.
As operations managers sourcing for USA labs, you know inconsistent assays inflate costs by 25-40%. Here's what frustrates 68% of researchers (2025 BioPharma Dive survey):
Your trials stall.These issues cost pharma firms $2.6B yearly in failed diabetes trials. What's your next step? Discover our fix below.
You demand ROI-focused solutions. Our USP crushes competitors:
| Spec | Our Kit | Competitor Avg |
|---|---|---|
| Sensitivity (Insulin) | 0.5 pM | 2 pM |
| CV (%) | <5% | 15-25% |
| Shelf Life | 24 months | 12 months |
| Components | Reagents, Plates, Protocol | Basic |
Case: Eli Lilly Partner – Integrated our assay in semaglutide screening; 40% faster hit identification, saving $500K.
Applications: Drug screening, toxicity, stem cell validation. Schedule a demo.

A kit measuring insulin secretion, viability in β-cells for diabetes research.
Quote via email/service@huanqiukeji9.com or +86 19943830844. Free shipping over $1K.
Yes, for iPSC/GSIS protocols. 4-week turnaround.
7-10 days, DHL. Duties pre-paid options.
24h troubleshooting, free replacements.
T/T, L/C, PayPal. USA-compliant.
Yes, for qualified labs. Apply now.
Risk-free: 30-day money-back. Contact now – stocks limited for Q1 2026.
Email: service@huanqiukeji9.com | Global Technology Co., Ltd, No. 14, 863 Park, Zhengzhou, China. Privacy policy: here.
"Outstanding β-Cell Function Assay! Reduced our assay time by 50% and costs by 35%. Highly recommend for USA labs." – Mike R., Operations Mgr, Bay Area Pharma. ★★★★★
"Quality beats any US supplier. GSIS data rock-solid, fast delivery. OEM service was seamless." – Dr. Lisa T., Harvard Med Lab. ★★★★★
"From quote to delivery in 8 days. Zero compliance issues. Saved us $10K on prototypes." – John K., Supply Chain Dir, Boston Biotech. ★★★★★
"Best service in the industry. Tech support fixed our protocol overnight." – Emma S., Technical Director, NYC Research. ★★★★★
Trusted by Industry Leaders
Certificates: GMP, DMF, FDA, ISO 9001, RoHS, CE. View COAs on request.